Ahmed AlHammadi

President of @EIDS_uae. Transplant ID physician. Adj Associate Prof UAEU. @UMass_ID @UT_infectious @bcm_tropmed alum #TxID #OncID #viewsmyown @docalhammadi

[Ahmed AlHammadi @TxIDdoc]

A 43-year-old man with pulmonary tuberculosis was started on standard anti-TB therapy. As expected, his uric acid level increased — a well-known effect of pyrazinamide. Although he had no history of gout or uric acid nephropathy, allopurinol was started to “prevent” complications

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Fosfomycin’s IV formulation is now being used more widely, particularly in critically ill patients with MDR or DTR-GNB infections
🆕⚡⚡🟢Excellent comprehensive review
Fosfomycin Use in Treating Severe Difficult-to-Treat Gram-Negative Infections
🔻Mechanism of action. Fosfomycin
🔻Antimicrobial Spectrum
🔻Resistance
🔻PK/PD Characteristics
🔻Dosing
🔻TDM
🔻Clinical Trials and Real-World Data
🔻Adverse Events
🔻ESCMID guidelines for the treatment of MDR GNB/fosfomycin
🔻Purposing Fosfomycin in the Treatment of DTR Gram-Negative Infections in Critically Ill Patients #IDXposts
https://t.co/tR3SDPoQ7n

[Clinical Infectious Diseases @CIDJournal]

Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures

✅ Just Accepted
✍️ @UCSFDHM
🔗 https://t.co/gLeQ6ti8N0

[Open Forum Infectious Diseases @OFIDJournal]

Effectiveness and safety of antibiotics in kidney transplant recipients with asymptomatic bacteriuria: a systematic review and meta-analysis of randomised controlled trials

✅ Just Accepted
🔗 https://t.co/cFXm1o4YyK

[Ahmed AlHammadi @TxIDdoc]

https://t.co/ohPrwUM01B

[Ahmed AlHammadi @TxIDdoc]

📢 Excited to share the publication of our landmark study on the Gam-COVID-Vac vaccine conducted in the UAE!

Proud to have led this work in collaboration with UAE University’s College of Medicine and Health Sciences.

https://t.co/sB8RGA4Xcj

[Open Forum Infectious Diseases @OFIDJournal]

Infection risk associated with colonization by multidrug-resistant Gram-negative bacteria: An umbrella review and meta-analysis

✅ Just Accepted
🔗 https://t.co/CfGMwpvbVS

[Ahmed AlHammadi @TxIDdoc]

Thrilled to have this episode discussion with Dr. Shoham on transplant infectious diseases in the UAE, commercial transplantation, and donor evaluation challenges. Grateful for the opportunity to share perspectives. #TransplantID #UAE

https://t.co/6xgBasVAGO

[Ahmed AlHammadi @TxIDdoc]

📢 New Publication Alert
Despite the proven efficacy of HIV PrEP, its uptake across the GCC remains far below potential barriers.

In our latest expert review, we outline a strategic roadmap to advance PrEP adoption in the region.

https://t.co/tKaVhzQZoI

[Ahmed AlHammadi @TxIDdoc]

Successful participation this year at the largest European Infectious Disease Conference ESCMID - European Society of Clinical Microbiology and Infectious Diseases in Vienna

Two posters presented which describe genomic analysis of 2 unique cases

[Ahmed AlHammadi @TxIDdoc]

@DrToddLee Very helpful .. thank you very much and best of luck!

[Ahmed AlHammadi @TxIDdoc]

@DrToddLee Amazing! What tool is that?

[transplantid.net @TransplantIDNet]

How safe and effective are MMR and VZV 💉after SOT in children? Pretty safe and pretty effective!

Need details? This 🔥table has it all in one place! The authors also propose inactivated vaccines >2 weeks pre-SOT and live vaccines >4 weeks

https://t.co/2uAa2vlAuo

[Dr sthanu subramanian @drsthanus]

Cytomegalovirus infection: When and why to detect antibodies.

Serological testing in CMV infection.

https://t.co/fd9AMh4QOu

[Clinical Infectious Diseases @CIDJournal]

Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial

✅ Just Accepted
🔗 https://t.co/yfmVOSeqOk

[Ahmed AlHammadi @TxIDdoc]

Publication Alert 🚨

This study aims to evaluate PrEP's value and effectiveness and to develop targeted recommendations for overcoming barriers and expanding PrEP programs to better serve the region's specific needs and populations at risk.

https://t.co/InqaSDfTwC

[Ahmed AlHammadi @TxIDdoc]

@ApuAkkad1 Thank you

[Ahmed AlHammadi @TxIDdoc]

Publication Alert 🚨

Unusual instance of heart involvement. A 28-year-old man from India presented with a persistent cough and hemoptysis. Imaging revealed bilateral lung lesions along with cystic lesions in his right ventricle.

https://t.co/IP6SkU4r5h

[EIDS_UAE @eids_uae]

We’re proud to announce the new EIDS board! With diverse expertise, they’ll lead us into an exciting new chapter ahead.

We also extend heartfelt gratitude to our outgoing members for their invaluable contributions.

Here's to growth and innovation ahead! #EIDS #Leadership

[Ahmed AlHammadi @TxIDdoc]

@ApuAkkad1 @TheTxIDjournal @AlmaghrabiReem @eids_uae @ema_abudhabi Thank you Dr Akkad

[Ahmed AlHammadi @TxIDdoc]

Thrilled to share that our editorial paper on “Organ vigilance in the Middle East: Challenges and prospects” was published today in @TheTxIDjournal

https://t.co/n8AiSua0F9

@AlmaghrabiReem
@eids_uae @ema_abudhabi